REQUEST A DEMO
Total
USD $0.00
Search more companies

Beijing Noah Defu Pharmaceutical Technology Sp. z o.o. (Poland)

Main Activities: Outpatient Care Centers
Secondary Activities: Merchant Wholesalers, Durable Goods | Retail Trade | General Freight Trucking | Couriers and Messengers | Warehousing and Storage | Real Estate Property Managers | Offices of Physicians
Full name: Beijing Noah Defu Pharmaceutical Technology Sp. z o.o. Profile Updated: January 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Beijing Noah Defu Pharmaceutical Technology Sp. z o.o. is based in Poland, with the head office in Warsaw. The enterprise operates in the Outpatient Care Centers industry. It was established on January 31, 2019. In 2021, the company reported a net sales revenue increase of 975.53%. Its’ total assets recorded a negative growth of 37.12%. In 2021, Beijing Noah Defu Pharmaceutical Technology Sp. z o.o.’s net profit margin increased by 484.44%.

Headquarters
Ul. Pulawska 39
Warsaw; Mazowieckie; Postal Code: 02-508

Contact Details: Purchase the Beijing Noah Defu Pharmaceutical Technology Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Beijing Noah Defu Pharmaceutical Technology Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Beijing Noah Defu Pharmaceutical Technology Sp. z o.o. report to view the information.
Incorporation Date:
January 31, 2019
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
40%
Purchase this report to view the information.
40%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Beijing Noah Defu Pharmaceutical Technology Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
975.53%
Total operating revenue
1030.42%
Operating profit (EBIT)
51.86%
EBITDA
51.98%
Net Profit (Loss) for the Period
51.85%
Total assets
-37.12%
Total equity
-49.51%
Operating Profit Margin (ROS)
484.44%
Net Profit Margin
484.44%
Return on Equity (ROE)
-69.72%
Quick Ratio
0.34%
Cash Ratio
0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?